ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/19/2023
Back to search
Official data from USPTO
PACIRA BIOSCIENCES, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/19/2023
Trademark type
Combined
Nice classes
42
Filing date
03/23/2021
Registration date
11/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/22/2022
Last transaction
11/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-04-00
First use in commerce
2019-04-00
Drawing code
3
Owner type
03
Owner location
Parsippany, NJ
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "PACIRA" in with an arch design running from the first "A" to the second "A" and the literal element "BIOSCIENCES, INC". directly underneath appearing in smaller font.
Holders and representatives
Holders
Pacira Pharmaceuticals, Inc.
Representatives
Vanessa A. Ignacio, Esq. LOWENSTEIN SANDLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development services; development and engineering services in the field of surgicaldiagnostic and therapeutic products; product development; design of new products for others; Design of medical goods for othersdrug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticalsmade to the order or specification of othersfor treatment of a wide variety of diseases
Publications
History of USPTO decisions and trademark events.
32 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/22/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/15/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/14/2022
DOCK
ASSIGNED TO EXAMINER
10/14/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/29/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/29/2022
IUAF
USE AMENDMENT FILED
09/16/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/16/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/27/2022
EX1G
SOU EXTENSION 1 GRANTED
07/25/2022
EXT1
SOU EXTENSION 1 FILED
07/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/25/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/26/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2021
PUBO
PUBLISHED FOR OPPOSITION
11/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/28/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/28/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/28/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/28/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/27/2021
GNRT
NON-FINAL ACTION E-MAILED
10/27/2021
CNRT
NON-FINAL ACTION WRITTEN
10/27/2021
DOCK
ASSIGNED TO EXAMINER
10/27/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2021
NWAP
NEW APPLICATION ENTERED
03/26/2021
Continuous trademark protection
Get notified about every new filing that threatens PACIRA BIOSCIENCES, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.